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Integrins play key roles in cell-to-cell and cell-to-extracellular matrix (ECM) adhesion. We investigated integrin
expression on pleural mesothelial cells (PMCs) and the inhibitory effect of arginine–glycine–asparate (RGD)-
containing peptide on the adhesion of PMCs to fibronectin and collagen.
Using flow cytometry and immunostaining, PMCs freshly isolated from pleural effusions and one mesothelial cell
line were screened for different integrins. Intact pleural tissue was evaluated by immunohistochemistry. The
adhesion of Met-5A cells to fibronectin and collagen types I, III and IV was assayed with prior treatment of various
concentrations of glycine–arginine–glycine–aspartate–serine (GRGDS).
On primary PMCs, a2, a3, a5, b1, b3 and avb3 were highly expressed (470%); a1 expression was intermediate
(30–70%); and a4 and a6 expressions were low (530%). On Met-5A cells, a3, a5, a6 and b1 were highly expressed
(470%); a1 was intermediate (30–70%); and a2, a4, b3 and avb3 were low (530%). The patterns of
immunostaining on pleural tissues were similar to the results of flow cytometry for primary PMCs except for b3.
There was no statistically different expression in various disease states (transudate vs. exudate, benign vs.
malignant). The inhibitory effect of GRGDS peptide on Met-5A cell adhesion to all four matrix proteins was
dose-dependent.
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Pleural mesothelial cells (PMCs) in the parietal and visceral
layers actively respond to extrinsic stimuli such as asbestos
fibres and micro-organisms, and to intrinsic inflammatory
mediators, resulting in the production of cytokines, growth
factors and extracellular matrix (ECM) (1,2). Many studies
have demonstrated that PMCs can produce a broad
spectrum of matrix components, including at least three
collagen types (I, III, IV), elastin, fibronectin and laminin
(3,4).
Cell-to-cell and cell-to-ECM adhesion has roles in
embryonic development, maintenance of tissue architec-
ture, inflammatory response, tumour metastasis and woundReceived 24 July 2000 and accepted in revised form 8 December
2000.
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0954-6111/01/030221+06 $35?00/0healing (5–7). Integrins, a family of cell adhesion molecules,
are heterodimers (a and b) that mediate cell-to-cell and
extracellular connections (8,9). Ligands of integrins include
collagen, laminin, fibronectin, fibrinogen and thrombo-
spondin (10,11). After interaction with ligands, the intra-
cellular domains of integrins form connections with
cytoskeleton that effect cell morphological change and
may be related to cellular attachment and detachment. In
response to asbestos, integrins on rabbit pleural mesothelial
cells can interact with ECM, causing the measothelial cells
to change shape (12).
The role of integrins in the adhesion of mesothelial cells
to pleural ECM in response to pleural injury has not been
widely reported previously. The purpose of this study was
to investigate the expression of integrins on human PMCs,
including primary human cell culture and immortalized
mesothelial cells (Met-5A). Mesothelial cells freshly isolated
from pleural effusions and Met-5A cells were screened for
different integrins using flow cytometry and immunostain-
ing, and the immunohistochemistry of intact pleural tissue
was evaluated. Disruption of cell–matrix interaction by# 2001 HARCOURT PUBLISHERS LTD
222 Y.-S. LIAW ET AL.arginine–glycine–aspartate (RGD)-containing peptide has
been shown to cause a number of diseases and pathogenic
processes (13,14). We therefore tested the inhibitory effect
of RGD-containing peptide on the adhesion of mesothelial
cells to fibronectin and collagen.
Materials and methods
REAGENTS
The screening antibodies conjugated to fluorescein isothio-
cyanate (FITC) were purchased from Becton Dickinson
Immunocytometry System (San Jose, CA, U.S.A.). Mouse
monoclonal antibody to cytokeratin (types I and II),
vimentin, CEA and desmin, and rabbit immunoglobulins
to von Willebrand factor antigen, were obtained from
Dakopatts (Denmark). Anti-integrin monoclonal antibo-
dies (mAbs) a1 (TS2/7), a2(JBS2), a3(11G5), a4(44H6),
a5(JB55), a6(4F10), avb3(23C6), b1(3S3) and b3(PM6/13)
were purchased from Serotec (Kidlington, Oxford, U.K.).
Extracellular matrix (ECM), including fibronectin (from
bovine plasma), collagen type III (acid-soluble from human
placenta) and collagen type IV (acid-soluble from human
placenta), was purchased from Sigma Chemical (St. Louis,
MO, U.S.A.) as was glycine–arginine –glycine aspartate–
serine (GRGDS) peptide. Collagen type I (from bovine
skin, vitrogen) was purchased from Celtrix Laboratories
(Palo Alto, CA, U.S.A.).
ISOLATION AND CULTURE OF HUMAN
PLEURAL MESOTHELIAL CELLS
Patients with moderate to massive pleural effusions under-
went thoracentesis for relieving respiratory distress. The
effusions were collected before chest tube insertion or other
interventions. Cytology for malignancy, biochemistry (total
protein, lactic dehydrogenase and sugar), cell counts and
cultures for micro-organisms were all checked on the
pleural effusion specimens.
Mesothelial cells were obtained from patients with
pleural effusion as described in previous reports (15,16).
Red blood cells in the effusions were removed by gradient
centrifugation. Then the pellet was washed once in RPMI
1640, resuspended in the same medium to a volume of 8–
10ml and seeded in 75-cm2 vitrogen-coated tissue culture
flasks in RPMI 1640 with 10% fetal calf serum. The
mesothelial cell cultures were maintained for two or three
passages at 378C in a humidified environment containing
5% CO2. Mesothelial cells were identified by their
morphological and immunohistochemical features: positive
staining for human cytokeratin (types I and II) and
vimentin and negative staining for CEA, desmin and von
Willebrand factor (17). The Met-5A mesothelial cell line,
produced from non-cancerous pleural effusion, was pur-
chased from American Type Culture Collection (Manassas,
VA, U.S.A.). The cells were transfected with pRSV-T
plasmid (containing the SV40 early region and the Roussarcoma virus long terminal repeat) and cloned. Medium
199 was used with 5% fetal bovine serum.
FLOW CYTOMETRY ANALYSIS
After trypsinizing and washing, 0?5716106 cells were
incubated with anti-integrin monoclonal antibodies
(30mgml71) for 30min at 48C and washed with PBS. In
negative controls, the primary antibody was omitted.
Subsequently, cells were incubated with FITC-conjugated
goat anti-mouse IgG or anti-rat IgG 30min at 48C and
again washed with PBS. Finally, fluorescence intensity was
analysed using the FACScan (Becton Dickinson, Mountain
View, CA, U.S.A.).
IMMUNOSTAINING OF PMCs AND
PLEURAL TISSUE
PMCs grown on cover slips were fixed with 0?1%
paraformaldehyde in PBS for 10min. After washing, the
cells were incubated with 20% normal goat whole serum in
PBS at 378C for 30min to block non-specific binding. After
extensive rinsing, the cells were incubated with monoclonal
anti-integrin subunit antibodies at 378C for 60min. After
washing, cells were incubated with FITC-conjugated goat
anti-mouse or anti-rat antibody at 378C for 60min. In
negative controls, the primary antibody was omitted.
Sections from eight pleural tissues, obtained from
patients who underwent lobectomy for bronchial tumour,
were cut at 10 mm in a cryostatic state. The immuno-
histochemistry was evaluated using the standard ABC
(avidin–biotin peroxidase complex) detecting system (18).
MET-5A MESOTHELIAL CELL ADHESION
ASSAY
Met-5A cells were suspended in M199 medium at a
concentration of 26105 cellsml71. Ninety-six-well tissue
culture plates had been separately coated with 50ml of
fibronectin (30 mgml71), collagen type I (80 mgml71),
collagen type III (80 mgml71) and collagen type IV
(80 mgml71) in PBS. After coating overnight at 48C, the
culture plates were washed with medium 199. Non-specific
binding was blocked with 50 ml of 1% BSA in medium 199
for 60min at 378C. A 200-ml aliquot of cells was pretreated
with various concentrations of GRGDS peptide (1?5, 15,
150mgml71) dissolved in M199 culture medium and
incubated for 30min in 5% CO2 at 378C. Cells were then
placed into each well and incubated for 90min at 378C.
Instead of GRGDS, we used M199 culture medium as
controls in each group. Non-adherent cells were removed
by aspiration and the attached cells were washed gently
with PBS. Adherent cells were fixed with 0?1% parafor-
maldehyde for 10min and stained with crystal violet for
1min. Adhesion was assessed by counting adherent cells
using a 1-mm2 reticle in an eyepiece at6100 magnification
in an inverted phase-contrast microscope. All experiments
were repeated in quadruplicate.
TABLE 1. Expression of integrins on primary human pleural






a1 63?7+ 17?5 37?7+ 1?1
a2 88?2+ 11?5 22?8+ 4?2
a3 97?7+ 3?5 98?5+ 0?9
a4 11?3+ 8?5 5?3+ 1?0
a5 86?7+ 11?5 79?3+ 4?9
a6 19?4+ 17?3 77?8+ 4?0
b1 98?0+ 6?6 99?4+ 0?2
b3 83?5+ 17?0 13?4+ 0?1
avb 3 90?5+ 10?7 27?5+ 2?5
PMC: Pleural mesothelial cells; %: percentage of cells in
test population positive for expression of integrins.
*Experiment, performed in triplicate. Data presented as
mean+SD.
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Statistical analysis was calculated by the Mann–Whitney U-
test or repeated measures ANOVA. A P-value less than
0?05 was considered statistically significant.
Results
PATIENTS
During a 1-year study period, pleural effusions were
collected from 26 patients for isolation of mesothelial cells.
There were 13 women and 13 men whose ages ranged from
15 to 78 years. Their underlying diseases included six cases
of liver cirrhosis, one liver abscess, two congestive heart
failures, one systemic lupus erythematosus, one Walden-
strom macroglobulinemia, nine primary lung cancers (eight
were non-small cell lung cancers) and six metastatic lung
cancers. The characteristics of pleural effusion included
eight transudates and 18 exudates. Eighteen were negative
and eight positive for malignancy.
INTEGRIN EXPRESSION ON PLEURAL
MESOTHELIAL CELLS AND MET-5A CELLS
Using flow cytometry, the expression of integrins on
primary PMCs can be arbitrarily classified into three
categories: high (470%), intermediate (30–70%) and low
(530%). a2, a3, a5, b1, b3 and avb3 were highly expressed
on the primary PMCs. The expression of a1 was inter-
mediate, and expressions of a4 and a6 were low (Table 1).
Immunostaining results were consistent with the flow
cytometry. Monoclonal antibodies specific to a2, a3, a5, b1,
b3 and avb3 were present in the PMCs grown on cover slips
[Fig. 1(a)] and there were fluorescence clusters on the
cellular surface. Fluorescence density was greater on theFIG. 1. (a) Indirect immunostaining for a3 on primary cultured
cytoplasm border (arrow). Magnification6200; m bar represen
tissue. Integrin a5 is confined on the uppermost layer of the pleu
Mangnification6200; m bar representing 50 mm in length.cytoplasm membrane borders. The expression of integrins
on Met-5A cells showed that a3, a5, a6 and b1 were high on
the surface, a1 was intermediate and a2, a4, b3 and avb3
were low (Table 1). The expressions of a2, a6, b3 and avb3
were different on primary PMCs and the Met-5A cell line.
The patterns of immunostaining on pleural tissues were
consistently similar to the results of flow cytometry for the
primary cultured PMCs. Integrins a2, a3, a5, b1 and avb3
were expressed on the cytoplasmic membrane of the flat
PMCs in the uppermost layer of the pleura [Fig. 1(b)].
Staining for a1, a4, a6 and b3 was negative.
There was no significantly different expression between
transudative and exudative effusions [Fig. 2(a)]. There also
was no difference between benign and malignant effusions
[Fig. 2(b)].human PMCs. Fluorescence density is greater on the
ting 25mm in length. (b) Immunostaining for intact pleural
ra, i.e. flat mesothelial cells with membrane staining (arrow).
FIG. 2. The expression of integrins on primary cultured human PMCs. (a) There was no difference in expression between
PMCS from transudative effusions (n¼ 8, &) and PMCs from exudative effusions (n¼ 18, ) (P40?05). (b) There was no
difference in expression between negative for malignancy (n¼ 18;&) and positive for malignancy (n¼ 8, ) (P40?05). Data
are expressed as median and range.
FIG. 3. The effect of RGD-containing peptide (GRGDS)
on Met-5A cell adhesion. All matrix proteins were coated
with collagen I, III and IV at 80 mgml71 and fibronectin
at 30 mgml71. With GRGDS pretreatment at 1?5 mgml71
(&), 15mgml71 (&) and 150 mgml71 ( ) the inhibition
effect on Met-5A cells occurred in a significantly dose-
dependent manner. Data are expressed as median and
range. The experiments were performed in quadruplicate.
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To avoid subjective selection, counting was analysed by two
persons who did not know the experimental conditions.
Since cells frequently adhere at the sharp edge on the
border of each well, adherent cells were counted exclusively
in these areas, as in a previous study (19). In each control
well (n¼ 4), adherent cells from six randomized sampling 1-
mm2 areas were 1481+209 (mean+SD) for collagen I,
1190+154 for collagen III, 1378+133 for collagen IV and
1627+144 for fibronectin. Figure 3, presenting inhibition
percentage, showed that GRGDS inhibited Met-5A cell
adhesion to all four matrix proteins in a dose-dependent
manner. With 1?5mgml71 GRGDS pretreatment, the
inhibition effect on collagen I and collagen III was
significantly higher than that on collagen IV and fibronectin
(P50?05 by ANOVA analysis). With 15mgml71 GRGDS
pretreatment, the inhibition effect on collagen I and
fibronectin was significantly higher than that on collagen
III and collagen IV (P50?05). With 150mgml71 GRGDS
pretreatment, the inhibition effect on fibronectin was the
most potent more than that on collagen I, III and IV
(P50?05).
Discussion
The subunits of integrins are expressed differently on
different cell types. Cultured mammalian cell lines possess
two to 10 integrins (7). In our study, flow cytometry showed
that more than 70% of the primary PMCs were positive for
a2, a3, a5, b1, b3 and avb3. Immunostaining showed the
same findings. However, on the Met-5A cell line the
expression of a2, b3 and avb3 decreased and a6 increased.
Immortalized transformation may cause the integrin
changes on cell surfaces. This result is compatible with
the study of integrin expression on pleural mesothelioma
and mesothelioma cell line (20,21). The expression of a6 is
intimately associated with neoplastic phenotype. The diff-
erent histotypes can affect in-vitro integrin expression andmay indicate a potential involvement of some subunits
in vivo during malignant mesothelioma tumour pro-
gression (22).
To determine the possibility of integrin change on PMCs
in culture, we examined the immunostaining of intact
pleural tissue. The patterns of immunostaining on the
pleura were similar to the flow cytometry except for b3. The
mesothelial cells on intact pleural tissue showed almost the
same integrin distribution as cultured cells. Integrin did not
change markedly in culture from the in-situ state. However,
the number of samples in this study was limited and further
investigation of the pleural tissues of various diseases in
needed.
The molecular mechanisms of desquamation of PMCs in
pleural injuries remain unknown. Disruption of cell–matrix
interaction, mediating integrin-dependent events, may lead
to cellular detachment and aggregation of desquamated
EXPRESSION OF INTEGRINS IN HUMAN CULTURED MESOTHELIAL CELLS 225cells (21,23). The counts of PMCs in pleural effusions are
significantly different in a variety of diseases. These cells are
uncommon in tuberculosis effusions but more common in
transudative effusions. We tested whether or not the
desquamation of PMCs occurs through changes of
integrins (24). However, our study failed to find significant
changes in the expression of integrins on PMCs in various
disease states (transudate vs. exudate; benign vs. malig-
nant). Desquamation may be caused by direct injury to
submesothelial ECM without integrin changes on PMCs.
Werb reported that proteolytic enzymes, produced by both
inflammatory cells and malignant cells, lead to change in
pleural permeability and pleural effusion formation (25).
Those enzymes could degrade the components of subpleur-
al ECM, resulting in a loss of both structural integrity and
cellular relationships. It is known that both fibronectin and
laminin are subject to proteolytic attack by neutral protease
and can be degraded in an inflammatory milieu (26).
Proteolytic degradation of ECM may account for the
detachment of mesothelial cells in vivo, but this theory must
remain a speculation with these data derived only from in-
vitro culture.
Integrins have three binding models: RGD for cell-
matrix, ICAM for cell-to-cell and fibrinogen (aIIbb3) for
platelets. The RGD binding site is found in a number of
ligands that interact with integrins including fibronectin,
vitronectin, collagen and a variety of other adhesive
proteins (27). The pairing of a and b exhibits high fidelity
in certain tissues and cell types. Approximately half the
known integrins, including a3b1, a5b1, avb1, avb3 and
avb5, express an RGD recognition specificity. In this study,
a synthetic RGD-containing peptide (GRGDS) inhibited
Met-5A cell adhesion to collagen types I, III and IV, and
fibronectin in a dose-dependent manner. Study of cell
adhesion inhibition by RGD peptides through integrin-
mediated processes should exclude the non-specific toxicity
of GRGDS. Previous studies showed incubation of
peritoneal mesothelial cells with GRGDS did not affect
cell viability (28). We also found the viability of PMCs was
not affected by GRGDS after 90min of incubation. At
150 mgml71, GRGDS was more potent in inhibiting
fibronectin- and collagen type I- than III- an IV-mediated
adhesion of Met-5A cells. This finding indicates that, as do
other types of cells [e.g. peritoneal mesothelial cells (28)],
PMCs possess RGD-dependent receptors.
A number of diseases and pathogenic processess are
candidates for intervention with RGD mimics. The
arginine–glycine–asparate (RGD) sequence of filamentous
haemagglutinin of Bordetella pertussis inhibited adherence
and transendothelial migration of neutrophils in an
experimental model of meningitis in rabbits (13). In the
study by Curtis et al., RGD-containing peptides altered the
endothelial permeability of bovine lung endothelial mono-
layers (14), suggesting that disruption of cell–matrix
interaction by RGD-containing peptides may be the
mechanism for change in cellular permeability. However,
the effect of RGD-containing peptides in permeability of
PMCs needs further investigation.
In conclusion, this study has established the character-
istic profiles for integrin expression on the surface of humanpleural mesothelial cells. a2, a3, a5, b1, b3 and avb3 are
highly expressed on primary cultured human PMCs and a3,
a5, a6 and b1 are highly expressed on the Met-5A cell line.
RGD-containing peptide can inhibit the adhesion of
mesothelial cells to ECM, including collagen I, III, IV
and fibronectin.
References
1. Kroegel C, Antony VB. Immunobiology of pleural
inflammation: potential implications for pathogenesis,
diagnosis and therapy. Eur Respir J 1997; 10:
2411–2418.
2. Wang NS. Anatomy of the pleura. Clin Chest Med
1998; 19: 229–240.
3. Rennard SI, Jaurand MC, Bignon J, et al. Role of
pleural mesothelial cells in the production of the
submesothelial connective tissue matrix of lung. Am
Rev Respir Dis 1984; 130: 267–274.
4. Davila RM, Crouch EC. Role of mesothelial and
submesothelial stromal cells in matrix remodeling
following pleural injury. Am J Pathol 1993; 142:
547–555.
5. Pilewski JM, Albelda SM. Adhesion molecules in the
lung: an overview. Am Rev Repir Dis 1993; 148:
S31–S37.
6. Danen EH, Lafrenie RM, Miyamoto S, et al. Integrin
signaling: cytoskeletal complexes, MAP kinase activa-
tion, and regulation of gene expression. Cell Adhesion
Comm 1998; 6: 217–224.
7. Howe A, Allin AE, Alahari SK, et al. Integrin signaling
and cell growth control. Curr Opin Cell Biol 1998; 10:
220–231.
8. Kroegel C, Matthys H. Adhesion molecules in diag-
nosis and therapy of respiratory disease. Respir Med
1992; 86: 455–457.
9. Hynes RO. Integrins: versatility, modulation, and
signaling in cell adhesion. Cell 1992; 69: 11–25.
10. Montefort S, Holgate ST. Adhesion molecules and
their role in inflammation. Respir Med 1991; 85: 91–99.
11. Kim LT, Yamada KM. The regulation of expression of
integrin receptors. Proc Soc Exp Biol Med 1997; 214:
123–131.
12. Boylan AM, Sanan DA, Sheppard D, Broaddus VC.
Vitronectin enhances internalization of crocidolite
asbestos by rabbit pleural mesothelial cells via the
integrin avb5. J Clin Invest 1995; 96: 1987–2001.
13. Rozdzinski E, Spellerberg B, van der Flier M, et al.
Peptide from a prokaryotic adhesin blocks leukocyte
migration in vitro and in vivo. J Infect Dis 1995; 172:
785–793.
14. Curtis TM, Mckeown-Longo PJ, Vincent PA, et al.
Fibronectin attenuates increased endothelial mono-
layer permeability after RGD peptide, anti-a5b1, or
TNF-a exposure. Am J Physiol 1995; 269: L248–260.
15. Indell S, Zwieb C, Kumar A, et al. Pathways of fibrin
turnover of human pleural mesothelial cells in vitro. Am
J Respir Cell Mol Biol 1992; 7: 414–416.
226 Y.-S. LIAW ET AL.16. Liaw YS, Yang PC, Yu CJ, et al. PKC activation is
required by EGF-stimulated Na-H exchanger activa-
tion in human pleural mesothelial cells. Am J Physiol
1998; 274: L665–L672.
17. Kuwahara M, Bijwaard KE, Gersten DM, et al.
Mesothelial cells produce a chemoattractant for lung
fibroblasts: role of fibronectin. Am J Respir Cell Mol
Biol 1991; 5: 256–264.
18. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-
peroxidase complex (ABC) in immunoperoxidase
technique: a comparison between ABC and unlabelled
antibody (PAP) procedure. J Histochem Cytochem
1981; 29: 577–580.
19. Yang CH, Huang TF, Liu KR, et al. Inhibition of
retinal pigment epithelial cell-induced tractional retinal
detachment by disintegrins, a group of Arg-Gly-Asp-
containing peptides from viper venom. Invest Ophthal-
mol Vis Sci 1996; 37: 843–854.
20. Koukoulis GK, Shen J, Monson R, et al. Pleural
mesothelioma have an integrin profile distinct from
visceral carcinomas. Hum Pathol 1997; 28: 84–90.
21. Barth TF, Bruderlein S, Rinaldi N, et al. Pleural
mesothelioma mimics the integrin profile of activated,
sessile rather than detached mesothelial cells. Int J
Cancer 1997; 72: 77–86.22. Giuffrida A, Vianale G, Di Muzio M, et al. Modulation
of integrin expression on mesotheliomas: the role of
different histotypes in invasiveness. Int J Oncol 1999;
15: 437–442.
23. Goligosky M, Noiri E, Kessler H, et al. Therapeutic
effect of arginin-glycine-aspartic acid peptides in acute
renal injury. Clin Exp Pharm Physiol 1998; 25: 276–279.
24. Light RW, Clinical manifestations and useful test. In:
Pleural diseases. Balitmore: Williams and Wilkins,
1995; 36–74.
25. Werb Z. Degradation of collagen. In: Weiss JB, Jayson
MIV, eds. Collagen in Health and Disease. Edinburgh:
Blackstone Livingstone, 1982; 121–134.
26. McDonald J, Baum B, Rosenberg D, et al. Destruction
of a major extracellular adhesive glycoprotein (fibro-
nectin) of human fibroblasts by neutral proteases from
polymorphonuclear leukocyte granules. Lab Invest
1979; 40: 350.
27. Cardarelli PM, Yamagata S, Taguchi I, et al. The
collagen receptor alpha 2 beta 1, from MG-63 and
HT1080 cells, interacts with a cyclic RGD peptide. J
Biol Chem 1992; 267: 23159–23164.
28. Yen CJ, Fang CC, Chen YM, et al. Extracellular
matrix proteins modulate human peritoneal mesothe-
lial cell behavior. Nephron 1997; 75: 188–195.
